“…Several studies have found that subanesthetic doses of the NMDA receptor antagonist ketamine induce psychoses-like symptoms in healthy volunteers ( Krystal et al, 1994 ; Malhotra et al, 1996 ). Ketamine influences memory ( Malhotra et al, 1996 ; Morgan and Curran, 2006 ) and modulates attentional processes ( Oranje et al, 2000 ; Watson et al, 2009 ; Gunduz-Bruce et al, 2012 ; Fuchs et al, 2015 ; von Düring et al, 2019 ; but see Morgan et al, 2004 ; van Wageningen et al, 2010 ). For example, Fuchs et al (2015) investigated the influence of ketamine on top-down attentional control using a visual cueing paradigm.…”